Skip Ribbon Commands
Skip to main content
Menu

Symposium 1



Asst. Prof Tang Hong-Wen

Assistant Professor
Cancer and Stem Cell Biology Programme
Duke-NUS Medical School

Dr. Tang Hong-Wen is an Assistant Professor in the Cancer and Stem Cell Program at Duke-NUS Medical School. He obtained his B.S. from National Tsing Hua University and received M.S. and Ph.D. from the Institute of Biochemistry at National Taiwan University. After mandatory military service, he accepted a position as a postdoctoral fellow in Dr. Norbert Perrimon's laboratory in the Department of Genetics at Harvard Medical School. He subsequently joined Duke-NUS Medical School as a Principal Investigator. His current research focuses on the muscle homeostasis and regeneration under pathological conditions. Dr. Tang's work has been published in several journals, such as Cell Metabolism, PNAS, and Nature Communications. He has been serving on the editorial board of multiple journals and was recently elected as a member in Sigma Xi.



Session:

Building from the Bench (Model Systems to Understand Disease Mechanisms)
12 April 2024, 1045 - 1215, NAK Auditorium

Presenting Title:

Deaf1 Regulates Muscle Regenaration Through Autophagy

The commonality between various muscle diseases is the loss of muscle mass, function, and regeneration, which severely restricts mobility and impairs the quality of life. With muscle stem cells (MuSCs) playing a key role in facilitating muscle repair, targeting regulators of muscle regeneration has been shown to be a promising therapeutic approach to repair muscles. However, the underlying molecular mechanisms driving muscle regeneration are complex and poorly understood. Here, we have identified a transcriptional factor, Deformed epidermal autoregulatory factor 1 (Deaf1), as a new regulator of muscle regeneration. We showed that Deaf1 targets to PI3KC3 and Atg16l1 promoter regions and suppresses their expressions, thus inhibiting autophagy. Deaf1 depletion therefore induces autophagy which blocks MuSC survival and differentiation. In contrast, Deaf1 overexpression inactivates autophagy in MuSCs, leading to increases in protein aggregates and cell death. The fact that Deaf1 depletion and overexpression both lead to defects in muscle regeneration highlights the importance of fine tuning of Deaf1-regulated autophagy during myogenesis. Significantly, we further showed that Deaf1 expression is altered in sarcopenic and cachectic MuSCs. Manipulation of Deaf1 expression can attenuate muscle atrophy and restore muscle regeneration in the mouse models of sarcopenia and cancer cachexia. Our findings together unveil a critical role for Deaf1 in muscle regeneration, providing insights into the development of uncovering new therapies against muscle atrophy.